Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solebury Strategic Communications is a private investor relations and corporate communications advisory firm that serves companies across sectors, with a notable specialization in life sciences. In healthcare, the firm works with biotechnology, specialty pharma, pharmaceutical and medical device companies on investor relations, corporate communications, media relations, capital-markets positioning, and messaging around clinical, regulatory, and commercial milestones. Its life sciences practice supports clients from early clinical data through regulatory approval and commercial launch, helping management teams communicate scientific and operational progress to investors, media, partners, patients, and the medical community. Solebury is not a drug developer and does not appear to own a therapeutic pipeline; rather, it is a services business supporting healthcare companies' financing and communications needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solebury Strategic Communications.